Cepheid's Q4 Revenues Rise 19 Percent on Strong Consumables Sales | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market Thursday that its fourth-quarter revenues increased 19 percent on strong consumables sales. The firm also turned a profit, which was not expected by Wall Street.

Cepheid brought in total revenues of $58.7 million for the three months ended Dec. 31, compared to revenues of $49.2 million for the fourth quarter of 2009. Analysts, on average, had expected $56.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.